The variable's highly significant parameter estimates, despite the low number of non-Caucasian patients included in the study, indicates that race may be an important predictor of patient QoL.
← all excerpts
Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.
1
—
—